Medical products firm Sterinova opens new $70M plant outside Montreal
Company to create more than 100 jobs, manufacture syringes and premix solution containers at new 67,000 square-foot facility
SAINT-HYACINTHE, Que.—An upstart medical products company has officially opened a new $70 million manufacturing plant just east of Montreal.
Backed by several government and corporate investors, Sterinova Inc. will make ready-to-use syringes and premix solution containers, such as intravenous bags, at the Saint-Hyacinthe, Que. facility.
The company has already hired 55 employees and anticipates adding 50 more over the short term. Equipped with fully-automated machinery, the plant covers 67,000 square-feet and was designed to allow for future expansion.
Jean-Philippe Gentès, the company’s president, said the new state-of-the-art site will make the company an important player in both the Canadian and international medical products markets.
Sterinova partnered with Fonds de solidarité FTQ, Quebec Manufacturing Fund, Saint-Hyacinthe Technopole, Desjardins Group, Investissement Québec and Canada Economic Development for Quebec Regions (CED) to secure funding for the new plant.